Immunogenic characterization and protection against Streptococcus mutans infection induced by intranasal DNA prime-protein boost immunization

Vaccine

Volumn 28, Issue 32, 2010, Pages 5370-5376

  Li, Yu Hong ^a   Huang, ShengFu ^a   Du, MinQuan ^a   Bian, Zhuan ^a   Chen, Zhi ^a   Fan, Ming Wen ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

Cytokine; Dental caries; Mucosal immune; Prime boost strategy; Th

Indexed keywords

BACTERIAL ANTIGEN; DNA VACCINE; GAMMA INTERFERON; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; INTERLEUKIN 4; PAC DNA VACCINE; UNCLASSIFIED DRUG; BACTERIAL PROTEIN; BACTERIUM ANTIBODY; CYTOKINE; RECOMBINANT PROTEIN; STREPTOCOCCUS VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENTAL CARIES; DNA IMMUNIZATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOGENICITY; MOUSE; MUCOSAL IMMUNITY; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOCOCCUS INFECTION; STREPTOCOCCUS MUTANS; ANIMAL; ANTIBODY PRODUCTION; BAGG ALBINO MOUSE; BLOOD; CELLULAR IMMUNITY; COMPARATIVE STUDY; GERMFREE ANIMAL; IMMUNIZATION; IMMUNOLOGY; INTRANASAL DRUG ADMINISTRATION; PLASMID; SPRAGUE DAWLEY RAT; STREPTOCOCCAL INFECTIONS;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, BACTERIAL; ANTIBODY FORMATION; BACTERIAL PROTEINS; CYTOKINES; DENTAL CARIES; FEMALE; IMMUNITY, CELLULAR; IMMUNITY, MUCOSAL; IMMUNIZATION, SECONDARY; MICE; MICE, INBRED BALB C; PLASMIDS; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; SPECIFIC PATHOGEN-FREE ORGANISMS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCAL VACCINES; STREPTOCOCCUS MUTANS; VACCINES, DNA;

EID: 77954953513     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.04.067     Document Type: Article

References (43)

1. Hamada S., Slade H.D. Biology, immunology, and cariogenicity of Streptococcus mutans. Microbiol Rev 1980, 44(2):331-384.
2. Russell M.W., Hajishengallis G., Childers N.K., Michalek S.M. Secretory immunity in defense against cariogenic mutans streptococci. Caries Res 1999, 33(1):4-15.
3. Koga-Ito C.Y., Martins C.A., Balducci I., Jorge A.O. Correlation among mutans streptococci counts, dental caries, and IgA to Streptococcus mutans in saliva. Braz Oral Res 2004, 18(4):350-355.
4. Han T.K., Dao M.L. Enhancement of salivary IgA response to a DNA vaccine against Streptococcus mutans wall-associated protein A in mice by plasmid-based adjuvants. J Med Microbiol 2007, 56(5):675-680.
5. Brandtzaeg P. Role of secretory antibodies in the defence against infections. Int J Med Microbiol 2003, 293(1):3-15.
6. Guo H., Wang X., Jiang G., Yang P. Construction of a sIgA-enhancing anti-Porphyromonas gingivalis FimA vaccine and nasal immunization in mice. Immunol Lett 2006, 107(1):71-75.
7. Hajishengallis G., Michalek S.M. Current status of a mucosal vaccine against dental caries. Oral Microbiol Immunol 1999, 14(1):1-20.
8. Smith D.J., Mattos-Graner R.O. Secretory immunity following mutans streptococcal infection or immunization. Curr Top Microbiol Immunol 2008, 319:131-156.
9. Russell M.W. Immunization against dental caries. Curr Opin Dent 1992, 2:72-80.
10. Koga T., Oho T., Shimazaki Y., Nakano Y. Immunization against dental caries. Vaccine 2002, 20(16):2027-2044.
11. Zhang P., Jespersgaard C., Lamberty-Mallory L., Katz J., Huang Y., Hajishengallis G., et al. Enhanced immunogenicity of a genetic chimeric protein consisting of two virulence antigens of Streptococcus mutans and protection against infection. Infect Immun 2002, 70(12):6779-6787.
12. Fan M.W., Bian Z., Peng Z.X., Zhong Y., Chen Z., Peng B., et al. A DNA vaccine encoding a cell-surface protein antigen of Streptococcus mutans protects gnotobiotic rats from caries. J Dent Res 2002, 81(11):784-787.
13. Tsuha Y., Hanada N., Asano T., Abei T., Yamaguchi S., Salam M.A., et al. Role of peptide antigen for induction of inhibitory antibodies to Streptococcus mutans in human oral cavity. Clin Exp Immunol 2004, 137(2):393-401.
14. Salam M.A., Katz J., Zhang P., Hajishengallis G., Michalek S.M. Immunogenicity of Salmonella vector vaccines expressing SBR of Streptococcus mutans under the control of a T7-nirB (dual) promoter system. Vaccine 2006, 24(23):5003-5015.
15. Jia R., Guo J.H., Fan M.W., Bian Z., Chen Z., Peng B., et al. Mucosal immunization against dental caries with plasmid DNA encoding pac gene of Streptococcus mutans in rats. Vaccine 2004, 22(20):2511-2516.
16. Wang S.W., Kozlowski P.A., Schmelz G., Manson K., Wyand M.S., Glickman R., et al. Effective induction of simian immunodeficiency virus-specific systemic and mucosal immune responses in primates by vaccination with proviral DNA producing intact but noninfectious virions. J Virol 2000, 74(22):10514-10522.
17. Jia R., Guo J.H., Fan M.W., Bian Z., Chen Z., Fan B., et al. Immunogenicity of CTKA4 fusion anti-caries DNA vaccine in rabbits and monkeys. Vaccine 2006, 24(24):5192-5200.
18. Hung C.F., Yang M., Wu T.C. Modifying professional antigen-presenting cells to enhance DNA vaccine potency. Methods Mol Med 2006, 127:199-220.
19. Lowe D.B., Shearer M.H., Jumper C.A., Kennedy R.C. Towards progress on DNA vaccines for cancer. Cell Mol Life Sci 2007, 64(18):2391-2403.
20. Chiarella P., Massi E., De Robertis M., Fazio V.M., Signori E. Strategies for effective naked-DNA vaccination against infectious diseases. Recent Pat Antiinfect Drug Discov 2008, 3(2):93-101.
21. Woodland D.L. Jump-starting the immune system: prime-boosting comes of age. Trends Immunol 2004, 25(2):98-104.
22. Radosević K., Rodriguez A., Lemckert A., Goudsmit J. Heterologous prime-boost vaccinations for poverty-related diseases: advantages and future prospects. Expert Rev Vac 2009, 8(5):577-592.
23. Bråve A., Boberg A., Gudmundsdotter L., Rollman E., Hallermalm K., Ljungberg K., et al. A new multi-clade DNA prime/recombinant MVA boost vaccine induces broad and high levels of HIV-1-specific CD8(+) T-cell and humoral responses in mice. Mol Ther 2007, 15(9):1724-1733.
24. Zhang G., Huong V.T., Battur B., Zhou J., Zhang H., Liao M., et al. A heterologous prime-boost vaccination regime using DNA and a vaccinia virus, both expressing GRA4, induced protective immunity against Toxoplasma gondii infection in mice. Parasitology 2007, 134(10):1339-1346.
25. Sha Z., Vincent M.J., Compans R.W. Enhancement of mucosal immune responses to the influenza virus HA protein by alternative approaches to DNA immunization. Immunobiology 1999, 200(1):21-30.
26. Childers N.K., Tong G., Michalek S.M. Nasal immunization of humans with dehydrated liposomes containing Streptococcus mutans antigen. Oral Microbiol Immunol 1997, 12(6):329-335.
27. Liu G.X., Xu Q.A., Jin J., Li Y.H., Jia R., Guo J.H., et al. Mucosal and systemic immunization with targeted fusion anti-caries DNA plasmid in young rats. Vaccine 2009, 27(22):2940-2947.
28. Navia J.M. Animal models in dental research 1977, University of Alabama Press, Tuscaloosa, p. 280.
29. Keyes P.H. Dental caries in the molar teeth of rats. II. A method for diagnosing and scoring several types of lesions simultaneously. J Dent Res 1958, 37(6):1088-1099.
30. Zuercher A.W., Coffin S.E., Thurnheer M.C., Fundova P., Cebra J.J. Nasal-associated lymphoid tissue is a mucosal inductive site for virus-specific humoral and cellular immune responses. J Immunol 2002, 168(4):1796-1803.
31. Ogra P.L., Faden H., Welliver R.C. Vaccination strategies for mucosal immune responses. Clin Microbiol Rev 2001, 14(2):430-445.
32. Fujihashi K., Kiyono H. Mucosal immunosenescence: new developments and vaccines to control infectious diseases. Trends Immunol 2009, 30(7):334-343.
33. Moore A.C., Hutchings C. Combination vaccines: synergistic simultaneous induction of antibody and T-cell immunity. Expert Rev Vac 2007, 6:111-121.
34. Lauterslager T.G., Stok W., Hilgers L.A. Improvement of the systemic prime/oral boost strategy for systemic and local responses. Vaccine 2003, 21(13-14):1391-1399.
35. Glynn A., Freytag L.C., Clements J.D. Effect of homologous and heterologous prime-boost on the immune response to recombinant plague antigens. Vaccine 2005, 23(6):1957-1965.
36. McCluskie M.J., Weeratna R.D., Payette P.J., Davis H.L. Parenteral and mucosal prime-boost immunization strategies in mice with hepatitis B surface antigen and CpG DNA. FEMS Immunol Med Microbiol 2002, 32(3):179-185.
37. Gherardi M.M., Najera J.L., Perez-Jimenez E., Guerra S., Garcia-Sastre A., Esteban M. Prime-boost immunization schedules based on influenza virus and vaccinia virus vectors potentiate cellular immune responses against human immunodeficiency virus Env protein systemically and in the genitorectal draining lymph nodes. J Virol 2003, 77(12):7048-7057.
38. Pulendran B. Modulating TH1/TH2 responses with microbes, dendritic cells, and pathogen recognition receptors. Immunol Res 2004, 29(2):187-196.
39. Wang S., Heilman D., Liu F., Giehl T., Joshi S., Huang X., et al. A DNA vaccine producing LcrV antigen in oligomers is effective in protecting mice from lethal mucosal challenge of plague. Vaccine 2004, 22(26):3348-3357.
40. Koopman G., Mortier D., Hofman S., Mathy N., Koutsoukos M., Ertl P., et al. Immune-response profiles induced by human immunodeficiency virus type 1 vaccine DNA, protein or mixed-modality immunization: increased protection from pathogenic simian-human immunodeficiency virus viraemia with protein/DNA combination. J Gen Virol 2008, 89(Pt 2):540-553.
41. Londoño-Arcila P., Freeman D., Kleanthous H., O'Dowd A.M., Lewis S., Turner A.K., et al. Attenuated Salmonella enterica serovar Typhi expressing urease effectively immunizes mice against Helicobacter pylori challenge as part of a heterologous mucosal priming-parenteral boosting vaccination regimen. Infect Immun 2002, 70(September (9)):5096-5106.
42. Robin G., Keisari Y., Slepon R., Ashkenazi S., Cohen D. Quantitative analysis of IgG class and subclass and IgA serum response to Shigella sonnei and Shigella flexneri 2a polysaccharides following vaccination with Shigella conjugate vaccines. Vaccine 1999, 17:3109-3115.
43. Heritage P.L., Underdown B.J., Arsenault A.L., Snider D.P., McDermott M.R. Comparison of murine nasal-associated lymphoid tissue and Peyer's patches. Am J Respir Crit Care Med 1997, 156(4):1256-1262.